Oman vs Qatar: HIV-positive TB patients on ART (antiretroviral therapy)
Oman
100.0%
in 2024
Qatar
100.0%
in 2024
Oman rank
1st
Qatar rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Oman
- Qatar
How they compare
Oman currently reports 100.0% against 100.0% in Qatar, a difference of 0.0%.
Across all 10 years both countries report, Qatar has been ahead every year.
Oman ranks 1st and Qatar ranks 1st of 144 countries.
Qatar has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Oman | Qatar | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 100.0% | 100.0% | 0.0% | — |
| 2010s | 86.7% | 100.0% | 13.3% | Qatar |
| 2020s | 91.4% | 100.0% | 8.6% | Qatar |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Oman or Qatar?
- Oman, at 100.0% against 100.0% in Qatar as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Oman and Qatar?
- 0.0%, with Oman ahead.
- How many years of comparable data are there for Oman and Qatar?
- 10 years are reported by both, from 2007 to 2024.
- How do Oman and Qatar rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Oman ranks 1st and Qatar ranks 1st of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.